Filed: 8/10/2023ACC: 0001104659-23-089542
📋 What this filing means
TEKLA CAPITAL MANAGEMENT LLC filed this quarterly 13F‑HR report disclosing 166 equity positions with a total reported market value of $2.56B. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
166
Positions
$2.56B
Total AUM (reported)
38.85M
Total Shares
Allocation by class
COMMON$2.26B88.4%
SPONSORED ADR$162.65M6.4%
SHARES$73.54M2.9%
CLASS A$27.07M1.1%
SPONSORED ADS$15.80M0.6%
S&P BIOTECH ETF$12.29M0.5%
NY REG SHARES$2.49M0.1%
Portfolio Concentration
Top 3$374.57M14.7%
4–10$655.60M25.7%
11–25$641.24M25.1%
Rest$883.97M34.6%
Top 3 weight
14.7%
Top 10 weight
40.3%
Voting Authority Distribution
Total shares with voting rights: 2.56B
Sole
Full voting authority
2.56B
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole166
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings166
Rows:
Amgen Inc.
SOLEShares616.54K
TypeSH
Market value$136.88M
5.36%
Sole
136.88M
Shared
0.00
None
0.00
Johnson & Johnson
SOLEShares721.78K
TypeSH
Market value$119.47M
4.68%
Sole
119.47M
Shared
0.00
None
0.00
Gilead Sciences, Inc.
SOLEShares1.53M
TypeSH
Market value$118.22M
4.63%
Sole
118.22M
Shared
0.00
None
0.00
Regeneron Pharmaceuticals, Inc.
SOLEShares161.42K
TypeSH
Market value$115.99M
4.54%
Sole
115.99M
Shared
0.00
None
0.00
Vertex Pharmaceuticals Inc.
SOLEShares318.04K
TypeSH
Market value$111.92M
4.38%
Sole
111.92M
Shared
0.00
None
0.00
Eli Lilly and Company
SOLEShares213.35K
TypeSH
Market value$100.06M
3.92%
Sole
100.06M
Shared
0.00
None
0.00
Unitedhealth Group Inc.
SOLEShares206.96K
TypeSH
Market value$99.47M
3.89%
Sole
99.47M
Shared
0.00
None
0.00
Merck & Co., Inc.
SOLEShares728.15K
TypeSH
Market value$84.02M
3.29%
Sole
84.02M
Shared
0.00
None
0.00
AbbVie Inc.
SOLEShares545.63K
TypeSH
Market value$73.51M
2.88%
Sole
73.51M
Shared
0.00
None
0.00
Biogen Inc.
SOLEShares247.94K
TypeSH
Market value$70.63M
2.76%
Sole
70.63M
Shared
0.00
None
0.00
AstraZeneca PLC
SOLEShares976.68K
TypeSH
Market value$69.90M
2.74%
Sole
69.90M
Shared
0.00
None
0.00
Illumina, Inc.
SOLEShares336.98K
TypeSH
Market value$63.18M
2.47%
Sole
63.18M
Shared
0.00
None
0.00
Abbott Laboratories
SOLEShares552.46K
TypeSH
Market value$60.23M
2.36%
Sole
60.23M
Shared
0.00
None
0.00
Pfizer Inc.
SOLEShares1.62M
TypeSH
Market value$59.59M
2.33%
Sole
59.59M
Shared
0.00
None
0.00
Thermo Fisher Scientific Inc.
SOLEShares98.99K
TypeSH
Market value$51.65M
2.02%
Sole
51.65M
Shared
0.00
None
0.00
Elevance Health, Inc.
SOLEShares114.07K
TypeSH
Market value$50.68M
1.98%
Sole
50.68M
Shared
0.00
None
0.00
Moderna, Inc.
SOLEShares343.69K
TypeSH
Market value$41.76M
1.63%
Sole
41.76M
Shared
0.00
None
0.00
Boston Scientific Corp.
SOLEShares657.79K
TypeSH
Market value$35.58M
1.39%
Sole
35.58M
Shared
0.00
None
0.00
Danaher Corp.
SOLEShares142.81K
TypeSH
Market value$34.28M
1.34%
Sole
34.28M
Shared
0.00
None
0.00
Medtronic plc
SOLEShares344.42K
TypeSH
Market value$30.34M
1.19%
Sole
30.34M
Shared
0.00
None
0.00
IDEXX Laboratories, Inc.
SOLEShares58.59K
TypeSH
Market value$29.43M
1.15%
Sole
29.43M
Shared
0.00
None
0.00
Dexcom, Inc.
SOLEShares228.75K
TypeSH
Market value$29.40M
1.15%
Sole
29.40M
Shared
0.00
None
0.00
Bristol-Myers Squibb Company
SOLEShares458.50K
TypeSH
Market value$29.32M
1.15%
Sole
29.32M
Shared
0.00
None
0.00
Intuitive Surgical, Inc.
SOLEShares83.98K
TypeSH
Market value$28.72M
1.12%
Sole
28.72M
Shared
0.00
None
0.00
Alnylam Pharmaceuticals, Inc.
SOLEShares143.21K
TypeSH
Market value$27.20M
1.06%
Sole
27.20M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Amgen Inc.SOLE | Common | 616.54K | SH | $136.88M 5.36% | 136.88M | 0.00 | 0.00 |
Johnson & JohnsonSOLE | Common | 721.78K | SH | $119.47M 4.68% | 119.47M | 0.00 | 0.00 |
Gilead Sciences, Inc.SOLE | Common | 1.53M | SH | $118.22M 4.63% | 118.22M | 0.00 | 0.00 |
Regeneron Pharmaceuticals, Inc.SOLE | Common | 161.42K | SH | $115.99M 4.54% | 115.99M | 0.00 | 0.00 |
Vertex Pharmaceuticals Inc.SOLE | Common | 318.04K | SH | $111.92M 4.38% | 111.92M | 0.00 | 0.00 |
Eli Lilly and CompanySOLE | Common | 213.35K | SH | $100.06M 3.92% | 100.06M | 0.00 | 0.00 |
Unitedhealth Group Inc.SOLE | Common | 206.96K | SH | $99.47M 3.89% | 99.47M | 0.00 | 0.00 |
Merck & Co., Inc.SOLE | Common | 728.15K | SH | $84.02M 3.29% | 84.02M | 0.00 | 0.00 |
AbbVie Inc.SOLE | Common | 545.63K | SH | $73.51M 2.88% | 73.51M | 0.00 | 0.00 |
Biogen Inc.SOLE | Common | 247.94K | SH | $70.63M 2.76% | 70.63M | 0.00 | 0.00 |
AstraZeneca PLCSOLE | Sponsored ADR | 976.68K | SH | $69.90M 2.74% | 69.90M | 0.00 | 0.00 |
Illumina, Inc.SOLE | Common | 336.98K | SH | $63.18M 2.47% | 63.18M | 0.00 | 0.00 |
Abbott LaboratoriesSOLE | Common | 552.46K | SH | $60.23M 2.36% | 60.23M | 0.00 | 0.00 |
Pfizer Inc.SOLE | Common | 1.62M | SH | $59.59M 2.33% | 59.59M | 0.00 | 0.00 |
Thermo Fisher Scientific Inc.SOLE | Common | 98.99K | SH | $51.65M 2.02% | 51.65M | 0.00 | 0.00 |
Elevance Health, Inc.SOLE | Common | 114.07K | SH | $50.68M 1.98% | 50.68M | 0.00 | 0.00 |
Moderna, Inc.SOLE | Common | 343.69K | SH | $41.76M 1.63% | 41.76M | 0.00 | 0.00 |
Boston Scientific Corp.SOLE | Common | 657.79K | SH | $35.58M 1.39% | 35.58M | 0.00 | 0.00 |
Danaher Corp.SOLE | Common | 142.81K | SH | $34.28M 1.34% | 34.28M | 0.00 | 0.00 |
Medtronic plcSOLE | Shares | 344.42K | SH | $30.34M 1.19% | 30.34M | 0.00 | 0.00 |
IDEXX Laboratories, Inc.SOLE | Common | 58.59K | SH | $29.43M 1.15% | 29.43M | 0.00 | 0.00 |
Dexcom, Inc.SOLE | Common | 228.75K | SH | $29.40M 1.15% | 29.40M | 0.00 | 0.00 |
Bristol-Myers Squibb CompanySOLE | Common | 458.50K | SH | $29.32M 1.15% | 29.32M | 0.00 | 0.00 |
Intuitive Surgical, Inc.SOLE | Common | 83.98K | SH | $28.72M 1.12% | 28.72M | 0.00 | 0.00 |
Alnylam Pharmaceuticals, Inc.SOLE | Common | 143.21K | SH | $27.20M 1.06% | 27.20M | 0.00 | 0.00 |
Page 1 of 7
…